Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 1;24(4):e555-e561.
doi: 10.4317/medoral.22976.

Nanosecond pulsed electric field inhibits malignant melanoma growth by inducing the change of systemic immunity

Affiliations

Nanosecond pulsed electric field inhibits malignant melanoma growth by inducing the change of systemic immunity

X Zhang et al. Med Oral Patol Oral Cir Bucal. .

Abstract

Background: Nanosecond pulsed electric fields (nsPEFs) showed an inhibitory effect on proliferation of malignant melanoma. In this study, the growth of melanoma were inhibited by changing the systemic immunity .

Material and methods: C57BL/6 mice with B16 malignant were exposed to 200 pulses of 100 ns duration, 30kV/cm. The mice were executed four days later. T lymphocyte has been extracted from spleen. Cell viability was evaluated by CCK-8 assay. CD3+CD4+ T cells, CD3+CD8+ T cells, regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSC) were analyzed by flow cytometry . TNF-α, IL-2, IL-10, TGF-β, IFN- γ levels in supernatants were assessed by ELISA.

Results: C57 malignant melanoma model were established successfully. After the treatment of nsPEFs(30 kV/cm 100 ns 200p), the numbers of T lymphocytes were increased.CD3+ CD4+ T cells changed from 48% to 51.2%;CD3+CD8+T lymphocytes increased from 39.6% to 40.4%.Treg cells reduced from 4.3% to 2.4%,MDSC decreased by 39.0% to 19.7% . In addition, the level of TNF-α, IL-2 were increased (P < 0.05) and the level of IL-10 were decreased (P < 0.05) and the level of TGF-β and IFN-γ remained stable (P > 0.05).

Conclusions: Tumor growth can be effectively inhibited by nsPEFs in vivo, which activate targets of immune respones, accumulation of inflammatory cells and immune cytokines.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement:The authors declare that they have no conflict of interests.

Figures

Figure 1
Figure 1
The change of C57BL/6 mice with B16 melanoma cells after treatment and extracted T lymphocytes from the spleen. 7 days after inoculation B16, the distribution of subcutaneous tumor can be found. Tumor-bearing mice treated by nsPEFs (Fig. 1B). Untreated tumor (Fig. 1A). The tumor with 30 kv,100 ns,100 pulses treated (Fig. 1C); the tumor with 30 kv,100 ns, 200 pulses treated (Fig. 1D). 4 days later, extracted T lymphocytes from the spleen (Fig. 1E). T cells morphology under a microscope(10x) (Fig. 1F). After treatment the survival rate of T lymphocytes increased in 24 hours and 48 hours compared with the untreated group (p< 0.05) (Fig. 1G,H).
Figure 2
Figure 2
The flow cytometry analysis. Compared with the untreaed group, the content of CD3+CD4+T cells and CD3+CD8+T lymphocytes were increased (Fig. 2A). In contrast, the cells of treg and MDSC were reduced (Fig. 2B,C) (n≥3 independent experiments).
Figure 3
Figure 3
The results showed that after treatment IL-2 and TNF-α concentration increased (p< 0.05) (A,B); the level of IL-10 decreased (P< 0.05) (C). IFN-γ, TGF-β had a rising trend, but no statistical difference (P>0.05) (D,E). All data are presented as means± standard deviations (n≥3 independent experiments).

Similar articles

Cited by

References

    1. Dvm A J, Bray F, Center M M, Bray F, Ferlay J, Ward E. Global cancer statistics(J) Ca A Cancer Journal for Clinicians. 2013;65:87–108. - PubMed
    1. Morimoto LM, Newcomb PA, White E, Bigler J, Potter J D. Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14:1204–1211. - PubMed
    1. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: Experience from treating 243 small renal masses over 7.5 years(J) Cancer. 2010;116:3135–3142. - PubMed
    1. Cheng K F, Leung PC. Use of Chinese Herbal Medicine as an Adjuvant for Cancer Treatment: A Randomized Controlled Dose-Finding Clinical Trial on Lung Cancer Patients. Journal of Cancer Therapy. 2011;2:3164–3164.
    1. Ang Y LE, Yong WP, Tan P. Translating gastric cancer genomics in-to targeted therapies. Critical Reviews in Oncology/Hematology. 2016;100:141–146. - PubMed